Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-008084
Filing Date
2015-10-30
Accepted
2015-10-30 16:16:13
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0915_actiniumpharma.htm 10-Q 767961
2 CERTIFICATION f10q0915ex31i_actinium.htm EX-31.1 11764
3 CERTIFICATION f10q0915ex32i_actinium.htm EX-32.1 5423
  Complete submission text file 0001213900-15-008084.txt   4147335

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE atnm-20150930.xml EX-101.INS 775911
5 XBRL SCHEMA FILE atnm-20150930.xsd EX-101.SCH 48207
6 XBRL CALCULATION FILE atnm-20150930_cal.xml EX-101.CAL 26400
7 XBRL DEFINITION FILE atnm-20150930_def.xml EX-101.DEF 155827
8 XBRL LABEL FILE atnm-20150930_lab.xml EX-101.LAB 399228
9 XBRL PRESENTATION FILE atnm-20150930_pre.xml EX-101.PRE 257227
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 151187695
SIC: 2834 Pharmaceutical Preparations